SCHEMBL4385437

SCHEMBL4385437

CCc1c(O)cc(O)c(-c2ccccc2)c1CCOCC(=O)N(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.39
SMN1; SMN2 Q16637 4/20 0.36
POLB P06746 3/20 0.36
RECQL P46063 2/20 0.36
ESR1 P03372 3/20 0.34
ESR2 Q92731 3/20 0.34
ALDH1A1 P00352 4/20 0.34
FABP4 P15090 2/20 0.34
FABP5 Q01469 2/20 0.34
HSD17B10 Q99714 2/20 0.34
KDM4E B2RXH2 2/20 0.34
NPC1 O15118 2/20 0.34
GAA P10253 2/20 0.34
HPGD P15428 2/20 0.34
RAB9A P51151 2/20 0.34
GLA P06280 1/20 0.34
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34
TACR3 P29371 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4395152 0.93 CNR2 (0.40) CNR2SMN1; SMN2POLBRECQLESR1
SCHEMBL4378125 0.86 CNR2 (0.43) CNR2SMN1; SMN2POLBRECQLESR1
SCHEMBL4389478 0.84 CNR2 (0.39) CNR2SMN1; SMN2POLBRECQLESR1
SCHEMBL4386674 0.80 ESR1 (0.39) CNR2SMN1; SMN2POLBRECQLESR1
SCHEMBL4386231 0.79 ESR1 (0.38) CNR2SMN1; SMN2POLBRECQLESR1
SCHEMBL4387022 0.79 CNR2 (0.44) CNR2SMN1; SMN2POLBRECQLESR1
SCHEMBL4387542 0.79 ESR1 (0.41) CNR2SMN1; SMN2POLBRECQLESR1
SCHEMBL4386915 0.78 EGFR (0.36) SMN1; SMN2POLBRECQLALDH1A1FABP4
SCHEMBL4377963 0.78 CNR2 (0.39) CNR2SMN1; SMN2POLBRECQLESR1
SCHEMBL4240306 0.77 CNR2 (0.40) CNR2SMN1; SMN2POLBRECQLESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538241-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070155813-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-07-05 US disclosed
EP-1704856-A1 HSP90 FAMILY PROTEIN INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155813-A1 Hsp90 family protein inhibitors HSP90AB1, HEATR1, HSP90AB2P CNR2 1898/4885SMN1; SMN2 4471/4885POLB 3913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.